Catalent Pharma Solutions, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/14 Q3

ended 12/31/13 Q2

ended 09/30/13 Q1

ended 06/30/13 FY 2013

ended 03/31/13 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Details of business combination or exchange offer

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer

Ownership

No filings in this category.

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Proxies

No filings in this category.

Other Filter

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice of effectiveness

Correspondence with the SEC